Older adults with glioblastoma lived longer with full treatment
Original title: Treatment intensity and survival benefit among older adults with glioblastoma: A population-based analysis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a look back at records of real patients, not a trial.
The short version
Older people who got surgery, radiation, and chemo lived longer than those who got no treatment.
What was studied. Researchers looked back at records of 21,206 people with glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. All were aged 65 or older. The records ran from 2000 to 2020. Full treatment meant surgery to remove all the tumor doctors could see, plus radiation and chemo.
What they found. Fewer people got the full treatment as age went up. About 54.3% of people aged 65 to 69 got it. Only 8.3% of people 85 and older got it. Over 24 months, full treatment added 11.1 to 8.2 months of life. That is compared with getting no treatment.
What this means, and what it doesn't
What it could mean: Age by itself may not be a good reason to skip treatment. It may help to ask the care team about surgery, radiation, and chemo together. The right choice still depends on your health and what matters to you.
What it doesn't mean: This is not a cure, and it is not a promise of more time. This was a look back at old records, not a trial. So it cannot prove that treatment caused people to live longer. The authors warn that healthier people may have been chosen for stronger treatment. That can make the treatment look better than it is. Full treatment is not right for everyone.
Source: PubMed, September 7, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.